Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (Weighted Average) (2021 - 2026)

HeartSciences' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $2.1 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) rose 135.18% year-over-year to $2.1 million; the TTM value through Jan 2026 reached $2.1 million, up 135.18%, while the annual FY2025 figure was $121055.0, 65.66% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $2.1 million in Q1 2026 per HSCS's latest filing, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $8.2 million in Q1 2023 to a low of $79506.0 in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $2.2 million, with a median of $917445.0 recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 98.46% in 2023, then soared 760.79% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $6.9 million in 2022, then plummeted by 98.46% to $106582.0 in 2023, then skyrocketed by 760.79% to $917445.0 in 2024, then soared by 128.57% to $2.1 million in 2025, then grew by 0.27% to $2.1 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Shares Outstanding (Weighted Average) are $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $1.3 million (Q3 2025).